EQL Pharma AB (FRA:7JK) Research & Development : €1.06 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. EQL Pharma AB's Research & Development for the three months ended in Mar. 2024 was €0.26 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €1.06 Mil.

EQL Pharma AB Research & Development Historical Data

The historical data trend for EQL Pharma AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Research & Development Chart

EQL Pharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Research & Development

Get a 7-Day Free Trial

1.15

0.87

1.35

1.07

EQL Pharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial															0.45	0.18	0.26	0.35	0.26

EQL Pharma AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.06 Mil.

EQL Pharma AB (FRA:7JK) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

EQL Pharma AB Research & Development Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

EQL Pharma AB (FRA:7JK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

EQL:Sweden

Address

Stortorget 1, 3rd Floor, Lund, SWE, 222 23

Website

http://www.eqlpharma.com

EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines